Skip to main content
. 2018 Jul 1;8(7):486. doi: 10.3390/nano8070486

Table 2.

The concentrations of mitoxantrone (MTO) and chemotherapy (CUR) in PCCM NPs on the treatments of HepG2 cells.

Drugs Concentration (μg/mL)
PCCM NPs-MTO 2.00 4.00 8.00 16.00 32.00
PCCM1-CUR 3.32 6.63 13.26 26.52 53.05
PCCM2-CUR 3.44 6.88 13.70 27.50 55.00
PCCM3-CUR 3.85 7.71 15.40 30.80 61.70